CASP3 and liver cancer: The dose-dependent increases in liver hypertrophy and liver organ weight previously reported8 align with known features of PPARα-induced liver cancer in rodents.38,39 The reevaluation of single-cell necrosis as apoptosis using updated diagnostic criteria described by Elmore et al10 was confirmed by caspase-3 staining.